000 | 01589 a2200457 4500 | ||
---|---|---|---|
005 | 20250513120133.0 | ||
264 | 0 | _c19970605 | |
008 | 199706s 0 0 eng d | ||
022 | _a0032-5473 | ||
024 | 7 |
_a10.1136/pgmj.73.858.194 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aMcAlister, F A | |
245 | 0 | 0 |
_aThe management of congestive heart failure. _h[electronic resource] |
260 |
_bPostgraduate medical journal _cApr 1997 |
||
300 |
_a194-200 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review | ||
650 | 0 | 4 |
_aAdrenergic beta-Antagonists _xtherapeutic use |
650 | 0 | 4 | _aAged |
650 | 0 | 4 | _aAged, 80 and over |
650 | 0 | 4 |
_aAngiotensin-Converting Enzyme Inhibitors _xtherapeutic use |
650 | 0 | 4 |
_aCardiovascular Agents _xtherapeutic use |
650 | 0 | 4 | _aClinical Trials as Topic |
650 | 0 | 4 | _aDiet, Sodium-Restricted |
650 | 0 | 4 |
_aDiuretics _xtherapeutic use |
650 | 0 | 4 | _aDrinking |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aHeart Failure _xepidemiology |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aMyocardial Ischemia _xtherapy |
650 | 0 | 4 | _aPrevalence |
650 | 0 | 4 | _aRisk Factors |
650 | 0 | 4 | _aSeverity of Illness Index |
650 | 0 | 4 |
_aVentricular Dysfunction, Left _xdiagnosis |
650 | 0 | 4 |
_aVentricular Dysfunction, Right _xdiagnosis |
650 | 0 | 4 |
_aWarfarin _xtherapeutic use |
700 | 1 | _aTeo, K K | |
773 | 0 |
_tPostgraduate medical journal _gvol. 73 _gno. 858 _gp. 194-200 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1136/pgmj.73.858.194 _zAvailable from publisher's website |
999 |
_c9137380 _d9137380 |